ਪ੍ਰੋਸਟੇਟ ਕੈਂਸਰ
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
ਕਿੱਥੇ ਜਾਣਾ ਹੈ
ਭਾਰਤ ਵਿੱਚ 8 ਹਸਪਤਾਲ ਇਸ ਟ੍ਰਾਇਲ ਲਈ ਮਰੀਜ਼ਾਂ ਨੂੰ ਲੈ ਰਹੇ ਹਨ।
ਰਜਿਸਟਰੀ ਸਮਰੀ (ਤਕਨੀਕੀ)
Researchers are looking for a better way to treat men who have non-metastatic castration-resistant prostate cancer (nmCRPC). This is a type of cancer of the prostate that has not yet spread to other parts of the body and that keeps progressing even when the amount of male sex hormones like testosterone (also called androgens) is reduced to very low levels. To reduce androgen levels in prostate cancer patients, androgen deprivation therapy (ADT) is often used. As androgens stimulate the growth of prostate cancer cells, low levels are needed to reduce or slow the growth of these tumors. In men …
ਸਪੌਂਸਰ: Bayer
ClinicalTrials.gov 'ਤੇ NCT05348876
ਰਜਿਸਟਰੀ 'ਤੇ ਆਖਰੀ ਅਪਡੇਟ 6 Jul 2026 · ਅਸੀਂ 20 Oct 2026 ਨੂੰ ਪੜ੍ਹਿਆ